Nio Y - Search Results

1

Ki-ras point mutation and p53 expression in human pancreatic cancer: a comparative study among Chinese, Japanese, and Western patients.

Dong M, Nio Y, Tamura K, Song MM, Guo KJ, Guo RX, Dong YT. Dong M, et al. Among authors: nio y. Cancer Epidemiol Biomarkers Prev. 2000 Mar;9(3):279-84. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10750666

2

Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer.

Yamasawa K, Nio Y, Dong M, Yamaguchi K, Itakura M. Yamasawa K, et al. Among authors: nio y. Clin Cancer Res. 2002 Aug;8(8):2563-9. Clin Cancer Res. 2002. PMID: 12171884

3

[Comparison of pBcl-2 and pBax expression in primary invasive ductal pancreatic cancer between Chinese and Japanese patients].

Zhou JP, Dong M, Nio Y, Kong FM, Zheng XY, Guo KJ. Zhou JP, et al. Among authors: nio y. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Oct;27(5):611-4. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005. PMID: 16274043 Chinese.

4

Clinicopathological significance of Ki-ras point mutation and p21 expression in benign and malignant exocrine tumors of the human pancreas.

Song MM, Nio Y, Sato Y, Tamura K, Furuse K. Song MM, et al. Among authors: nio y. Int J Pancreatol. 1996 Oct;20(2):85-93. doi: 10.1007/BF02825506. Int J Pancreatol. 1996. PMID: 8968863

5

p53 protein expression as prognostic factor in human pancreatic cancer.

Sato Y, Nio Y, Song MM, Sumi S, Hirahara N, Minari Y, Tamura K. Sato Y, et al. Among authors: nio y. Anticancer Res. 1997 Jul-Aug;17(4A):2779-88. Anticancer Res. 1997. PMID: 9252715

6

Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer.

Uegaki K, Nio Y, Inoue Y, Minari Y, Sato Y, Song MM, Dong M, Tamura K. Uegaki K, et al. Among authors: nio y. Anticancer Res. 1997 Sep-Oct;17(5B):3841-7. Anticancer Res. 1997. PMID: 9427790

7

Comparative study of p53 expression in primary invasive ductal carcinoma of the pancreas between Chinese and Japanese.

Dong M, Nio Y, Sato Y, Tamura K, Song MM, Tian YL, Dong YT. Dong M, et al. Among authors: nio y. Pancreas. 1998 Oct;17(3):229-37. doi: 10.1097/00006676-199810000-00002. Pancreas. 1998. PMID: 9788535

8

Epidermal growth factor and its receptor as prognostic indicators in Chinese patients with pancreatic cancer.

Dong M, Nio Y, Guo KJ, Tamura K, Tian YL, Dong YT. Dong M, et al. Among authors: nio y. Anticancer Res. 1998 Nov-Dec;18(6B):4613-9. Anticancer Res. 1998. PMID: 9891528

9

Comparison of K-ras point mutations at codon 12 and p21 expression in pancreatic cancer between Japanese and Chinese patients.

Song MM, Nio Y, Dong M, Tamura K, Furuse K, Tian YL, He SG, Shen K. Song MM, et al. Among authors: nio y. J Surg Oncol. 2000 Nov;75(3):176-85. doi: 10.1002/1096-9098(200011)75:3<176::aid-jso5>3.0.co;2-w. J Surg Oncol. 2000. PMID: 11088049

10

p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.

Dong M, Nio Y, Yamasawa K, Toga T, Yue L, Harada T. Dong M, et al. Among authors: nio y. J Surg Oncol. 2003 Feb;82(2):111-20. doi: 10.1002/jso.10186. J Surg Oncol. 2003. PMID: 12561067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters